Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MEX3D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LYPD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00305 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC17A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SMCO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OPN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HBG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMCHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF519 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRRS1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZXDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHV4-31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on